Crea il mio profilo
Accesso pubblico
Visualizza tutto26 articoli
4 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Anastasia KhvorovaUMASS Medical SchoolEmail verificata su umassmed.edu
- Andrew ColesUniversity of Massachusetts Medical schoolEmail verificata su umassmed.edu
- Dimas EcheverriaAssoc Director of Nucleic Acid Chemistry Center, UMass Medical SchoolEmail verificata su umassmed.edu
- Matthew HasslerUmass Medical SchoolEmail verificata su mail.mcgill.ca
- Marie DidiotUniversity of Massachusetts Medical SchoolEmail verificata su umassmed.edu
- Bruno M.D.C. GodinhoAtalanta TherapeuticsEmail verificata su atalantatx.com
- Julia AltermanUniversity of Massachusetts Medical SchoolEmail verificata su umassmed.edu
- Annabelle BiscansAstraZeneca R&D, SwedenEmail verificata su astrazeneca.com
- Maire F. OsbornRNA Therapeutics Institute | Univ. of Massachusetts Medical SchoolEmail verificata su umassmed.edu
- Michelle DubukeUMass Medical SchoolEmail verificata su umassmed.edu
- Socheata LySenior Scientist, ReNAgade TherapeuticsEmail verificata su renagadetx.com
- Steptoe AUniversity College LondonEmail verificata su ucl.ac.uk
- Samantha DockrayUniversity College CorkEmail verificata su ucc.ie
- Melissa J. MooreModerna Therapeutics/UMass Medical SchoolEmail verificata su umassmed.edu
- Jonathan K. WattsProfessor, RNA Therapeutics Institute, UMass Chan Medical SchoolEmail verificata su umassmed.edu
- Vivek SharmaUniversity of Massachusetts Chan Med School, USAEmail verificata su umassmed.edu
- Gregory S Thomas, MD, MPHMedical Director Emeritus, Cardiovascular Program Development, MemorialCare Heart & VascularEmail verificata su memorialcare.org